SEC Form 4 · accession 0001645627-17-000106
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 11, 2017
Accepted (ET)
Aug 15, 2017 · 2:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0292 | A | 22,307,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.026 | A | 22,309,889 | D | |
| Common Stock | Aug 11, 2017 | P | 5,000 | $0.0289 | A | 22,314,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0285 | A | 22,316,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0285 | A | 22,318,889 | D | |
| Common Stock | Aug 11, 2017 | P | 5,000 | $0.0285 | A | 22,323,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0285 | A | 22,325,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0285 | A | 22,327,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0285 | A | 22,329,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0285 | A | 22,331,889 | D | |
| Common Stock | Aug 11, 2017 | P | 2,000 | $0.0281 | A | 22,333,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,700 | $0.026 | A | 22,336,589 | D | |
| Common Stock | Aug 14, 2017 | P | 300 | $0.0269 | A | 22,336,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0269 | A | 22,338,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0269 | A | 22,340,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0269 | A | 22,342,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0269 | A | 22,344,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0267 | A | 22,346,889 | D | |
| Common Stock | Aug 14, 2017 | P | 5,000 | $0.0269 | A | 22,351,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0268 | A | 22,353,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0269 | A | 22,355,889 | D | |
| Common Stock | Aug 14, 2017 | P | 5,000 | $0.0269 | A | 22,360,889 | D | |
| Common Stock | Aug 14, 2017 | P | 5,000 | $0.0249 | A | 22,365,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.025 | A | 22,367,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.025 | A | 22,369,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.027 | A | 22,371,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.027 | A | 22,373,889 | D | |
| Common Stock | Aug 14, 2017 | P | 2,000 | $0.0269 | A | 22,375,889 | D | |
| Common Stock | Aug 14, 2017 | P | 11,000 | $0.0269 | A | 22,386,889 | D | |
| Common Stock | Aug 14, 2017 | P | 3,000 | $0.0269 | A | 22,389,889 | D |
Table II — derivative securities
No Table II lines on this filing.